Dupixent and Nerve compression - a phase IV clinical study of FDA data

Summary:

Nerve compression is reported as a side effect among people who take Dupixent (dupilumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Nerve compression when taking Dupixent. It is created by eHealthMe based on reports of 257,518 people who have side effects when taking Dupixent from the FDA, and is updated regularly.

What is Dupixent?

Dupixent has active ingredients of dupilumab. eHealthMe is studying from 257,631 Dupixent users. Check the latest studies of Dupixent.

What is Nerve compression?

Nerve compression is found to be associated with 799 drugs and 675 conditions by eHealthMe. Check the latest studies of Nerve compression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

257,518 people reported to have side effects when taking Dupixent.
Among them, 97 people (0.04%) have Nerve compression.

Among these 97 people:

How long have people been on Dupixent when they have Nerve compression? *

What is the gender of people who have Nerve compression when taking Dupixent? *

female: 69.89 %
male: 30.11 %

What is the age of people who have Nerve compression when taking Dupixent? *

What are other drugs people take besides Dupixent? *

What are other side effects people have besides Nerve compression? *

Hypoaesthesia (reduced sense of touch or sensation): 14 people, 14.43%
Joint Pain: 11 people, 11.34%
Itching: 8 people, 8.25%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 8 people, 8.25%
Back Pain: 7 people, 7.22%
Pain: 7 people, 7.22%
Pain In Extremity: 6 people, 6.19%
Headache (pain in head): 6 people, 6.19%
Weakness: 6 people, 6.19%
Injection Site Pain: 6 people, 6.19%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 54 people, 55.67%
Asthma: 18 people, 18.56%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 6 people, 6.19%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 5.15%
Nasal Polyps (masses that develop in the lining of the nose): 4 people, 4.12%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 2 people, 2.06%
Stress And Anxiety: 1 person, 1.03%
Solar Urticaria (an abnormal reaction to sunlight): 1 person, 1.03%
Sinusitis (inflammation of sinus): 1 person, 1.03%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.03%

* Approximation only. Some reports may have incomplete information.

Do you take Dupixent and have Nerve compression?

- Check whether Nerve compression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dupixent:

Dupixent (257,631 reports)

Browse all side effects of Dupixent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nerve compression:

Nerve compression (799 drugs)

Browse all the conditions that are associated with Nerve compression:

Nerve compression (675 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dupilumab (the active ingredients of Dupixent) and Dupixent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.